4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Curatis Holding AG (CURN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Liestal, Switzerland with about 9 employees. Its market capitalization is roughly CHF 95 million. In the fiscal year ended 2025-12-31, CURN reported CHF 11M in revenue and (CHF 1M) in net income.
Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 11M | CHF 7M | CHF 0M | CHF 0M | — |
| Gross Profit | CHF 3M | CHF 2M | CHF 0M | — | — |
| Operating Income (EBIT) | (CHF 2M) | (CHF 3M) | (CHF 4M) | (CHF 2M) | — |
| Net Income | (CHF 1M) | (CHF 4M) | (CHF 49M) | (CHF 35M) | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 56M | CHF 56M | CHF 0M | CHF 14M | — |
| Total Liabilities | CHF 10M | CHF 10M | CHF 0M | CHF 7M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CURN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms